WEDNESDAY, July 5, 2006 (HealthDay News) -- The first generic versions of the popular antidepressant Zoloft (sertraline) have been approved by the U.S. Food and Drug Administration.
Last year, Pfizer's Zoloft was the sixth-best selling drug in the United States with retail sales of more than $2.5 billion, the agency said in a statement. The company's patent expired last week.
Israeli generic drugmaker Teva Pharmaceuticals plans to launch its version of Zoloft later this month, the Associated Press reported.
Generics, less expensive than brand-name equivalents, accounted for about two-thirds of U.S. prescription drug sales in 2004, the FDA said.
For more information about Zoloft, visit the National Library of Medicine.